When you go to “COOKIES INCL. ALLOW US SERVICES” click, you agree to the storage of cookies on your device to improve website navigation, analyze site usage, and support our marketing efforts. For more information, see our Privacy statement.

8.5.2023

Autologous Cartilage Transplant: An interview with Dr. Wolfgang Zinser

Cartilage damage, a ticking time bomb? What starts with an untreated local cartilage defect often leads to osteoarthritis. Unfortunately, advanced inflammation affects the entire knee joint, which leads to a decrease in the quality of life.

Dr. Wolfgang Zinser, specialist in orthopedics and traumatology, talks in an interview while sitting next to a spine model in his office.

In the Interview series with Dr. Wolfgang Zinser The specialist in orthopedics and traumatology reports on the characteristics of a cartilage defect, the chances of recovery and suitable therapeutic procedures, such as Autologous cartilage cell transplantation with Spherox. Early treatment promises an optimal prognosis: The prevention of an artificial knee joint and rapid recovery time. Studies and testimonials speak for themselves: 80 percent of patients are still with the Very satisfied result.

Would you like to know more about treatment? On our Spherox product page, you can also download all information!

To the official website of Dr. Wolfgang Zinser

Für weitere Informationen kontaktieren Sie bitte:

More posts

Product Update

Long-term study proves lasting success with HyaloFast

A recent long-term study (Whyte et al. 2024) confirms the sustainable effectiveness of HyaloFast.
Sponsoring

Haemo Pharma as ADMIRA Wacker's new healthcare partner

Hämo Pharma is pleased to announce its partnership with the traditional soccer club ADMIRA Wacker.
Product Presentation

Stem cell therapy for degenerative joint diseases

In an Ö24 interview, Prof. Dr. Zimpfer provides insights into stem cell therapy and new approaches .

Make evidence-based decisions

Learn more about our scientifically researched products. Please feel free to contact us for further information.